Does APIXABAN Cause Hypersensitivity? 607 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 607 reports of Hypersensitivity have been filed in association with APIXABAN (ELIQUIS). This represents 0.4% of all adverse event reports for APIXABAN.
607
Reports of Hypersensitivity with APIXABAN
0.4%
of all APIXABAN reports
24
Deaths
118
Hospitalizations
How Dangerous Is Hypersensitivity From APIXABAN?
Of the 607 reports, 24 (4.0%) resulted in death, 118 (19.4%) required hospitalization, and 27 (4.4%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for APIXABAN.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which APIXABAN Alternatives Have Lower Hypersensitivity Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ